CN107080805A - Chinese medicine composition and preparation method for treating coronary heart disease - Google Patents
Chinese medicine composition and preparation method for treating coronary heart disease Download PDFInfo
- Publication number
- CN107080805A CN107080805A CN201710219548.9A CN201710219548A CN107080805A CN 107080805 A CN107080805 A CN 107080805A CN 201710219548 A CN201710219548 A CN 201710219548A CN 107080805 A CN107080805 A CN 107080805A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- heart disease
- coronary heart
- whitewashing
- maltodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 27
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 27
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 27
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 26
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 26
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 26
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 26
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 13
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 13
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 13
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 13
- 241000234435 Lilium Species 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 13
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 13
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 13
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 12
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 12
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 12
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 12
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 12
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 12
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 12
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 12
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 12
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 12
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 11
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 10
- 238000005469 granulation Methods 0.000 claims abstract description 7
- 230000003179 granulation Effects 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 3
- 239000000463 material Substances 0.000 claims description 61
- 230000033228 biological regulation Effects 0.000 claims description 14
- 238000011049 filling Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 235000020985 whole grains Nutrition 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000011017 operating method Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000002002 slurry Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 241000825107 Hierochloe Species 0.000 claims 1
- 235000015466 Hierochloe odorata Nutrition 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 27
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 16
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 230000004087 circulation Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 206010002383 Angina Pectoris Diseases 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 241000229143 Hippophae Species 0.000 description 10
- 241001092040 Crataegus Species 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000005243 fluidization Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 240000005809 Prunus persica Species 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000006278 hypochromic anemia Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- 206010051093 Cardiopulmonary failure Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012118 Defect conduction intraventricular Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033664 Panic attack Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013176 antiplatelet therapy Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OIRCOABEOLEUMC-GEJPAHFPSA-N bivalirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 OIRCOABEOLEUMC-GEJPAHFPSA-N 0.000 description 1
- 229960001500 bivalirudin Drugs 0.000 description 1
- 108010055460 bivalirudin Proteins 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 229960003009 clopidogrel Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000009524 danshen dripping Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000009465 diaoxinxuekang Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- OTKCDFNVBPBSNB-UHFFFAOYSA-N nitric acid;propane-1,2,3-triol Chemical compound O[N+]([O-])=O.OCC(O)CO OTKCDFNVBPBSNB-UHFFFAOYSA-N 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of Chinese medicine composition and preparation method for being used to treat coronary heart disease, and the Chinese medicine composition is composed of the following components by mass percentage:Hawthorn 5%~7%, Longstamen Onion Bulb 3%~5%, cloves 3%~5%, lily 5%~7%, peach kernel 11%~13%, the root of kudzu vine 5%~7%, Semen sesami nigrum 5%~7%, spina date seed 5%~7%, mulberry fruit 5%~7%, dried orange peel 3%~5%, arillus longan 5%~7%, Poria cocos 5%~7%, sea-buckthorn 5%~7%, Radix Angelicae Sinensis 11%~13%, rhizoma imperatae 5%~7%, radix glycyrrhizae 3%~5%.Will above-mentioned component mix after add water be boiled into after paste with maltodextrin and potassium sorbate mixing granulation, dry, sterilizing,.The present invention has promoting blood circulation and removing blood stasis, fat eliminating, the work(of promoting qi circulation and relieving pain, to reach the purpose for the treatment of coronary heart disease;Whole prescription scientific compatibility, the property of medicine is gentle, and human body is had no toxic side effect, can long-term taking.
Description
Technical field
The invention belongs to the Chinese medicine composition of integration of drinking and medicinal herbs category, and in particular to a kind of Chinese medicine group for being used to treat coronary heart disease
Compound and preparation method.
Background technology
Coronary cardiopathy abbreviation coronary heart disease, refers to because lipid-metabolism is abnormal, and the lipid calmness in blood exists
On the endarterium of otherwise smooth, in endarterium, some similar athero- lipid material accumulations are referred to as moved into white patch
Pulse atherosclerosis lesion.These patches increase gradually causes lumen of artery narrow, blood flow is obstructed, and causes heart ischemia, produces the heart
Angina.The two big causes of disease of coronary heart disease are coronary atherosclerosis and coronarospasm, and five big pathogenesis basis are:Hypertension,
High fat of blood, hyperglycaemia, advanced age, high body weight, eight big inducements are:Fatigue, heavy meal, catch cold, meet an urgent need, infecting, performing the operation, smoking of indulging in excessive drinking,
It is excited.
The method of western medical treatment coronary heart disease is mainly:Antiplatelet therapy, anticoagulant therapy, lipid-loweringing and anti-inflammatory treatment;Anti- blood
Platelet medicine is the aggregation or activation by obstructed approach blocking platelet, can effectively prevent the formation of coronary artery thrombosis, often
It is aspirin and clopidogrel to have medicine;The key agents of anticoagulant therapy are bivalirudin;The method of lipid-lowering therapy is to improve
HDL, reduction low-density lipoprotein, cholesterol and triglyceride, to stablize the lipid spot at coronary artery pathological changes
Block, prevents it from rupturing and expanding, or even can cut down Lipid Plaque, and key agents are Statins, fibrates, resinae and nicotinic acid
Class.Coronary heart disease needs Long-term taking medicine, somewhat expensive, and doctor trained in Western medicine toxic side effect is larger, and liver kidney is damaged, and can not be from
The precipitation again that the rubbish such as vascular lipids are solved on source forms new patch, causes blood vessel restenosis, blocking, and cardiac muscle is supplied
The problem of not smooth old disease of blood recurs.
The traditional Chinese medical science thinks, coronary heart disease is chest impediment and cardialgia disease, often because of inadequate natural endowment, will lose the day after tomorrow and supports, and both interact institute for a long time
Cause;Inadequate natural endowment is mainly manifested in heart-kidney yang deficiency, or the deficiency of liver-yin and kidney-yin;Lose the day after tomorrow to support and then include emotional stimulation, diet satiety, impression
Cold, overstrain and induce, its etiology and pathogenesis mainly has aged debility, improper diet, disorder of emotion, inward invasion of pathogenic cold, kidney qi
Empty sorrow, deficiency of kidney-YIN can not then nourish the moon of the five internal organs, can cause the heart-yin in-fighting, and the heart-yin virtual loss, heart-yang deficiency can make qi and blood again
Operation is lost freely, and general rule pain hair is this disease, and basic pathogenesis is qi deficiency to blood stasis.The conventional medicine for the treatment of coronary disease with traditional Chinese medicine has " Kang Er
Heart capsule and pill " and " compound danshen dripping pills ", the major function of both medicines is enriching yin and nourishing kidney, beneficial blood promoting blood circulation, reducing blood lipid, but is treated
Effect is not good.
The content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition for treating coronary heart disease, using the treatment means of solid decoction of medicinal ingredients,
For the treatment of coronary heart disease, to overcome the problem of Chinese medicine therapeutic effect of existing treatment coronary heart disease is undesirable.
The technical solution adopted in the present invention is,
Chinese medicine composition for treating coronary heart disease, it is by mass percentage, raw materials used composed of the following components:
Hawthorn 5%~7%, Longstamen Onion Bulb 3%~5%, cloves 3%~5%, lily 5%~7%, peach kernel 11%~13%, Pueraria lobota
Root 5%~7%, Semen sesami nigrum 5%~7%, spina date seed 5%~7%, mulberry fruit 5%~7%, dried orange peel 3%~5%, arillus longan 5%
~7%, Poria cocos 5%~7%, sea-buckthorn 5%~7%, Radix Angelicae Sinensis 11%~13%, rhizoma imperatae 5%~7%, radix glycyrrhizae 3%~5%, with
The mass percent summation of upper each component is 100%.
A kind of preparation method for being used to treat coronary heart disease Chinese medicine composition, including following operating procedure:
Step 1,
By mass percentage, weigh hawthorn 5%~7%, Longstamen Onion Bulb 3%~5%, cloves 3%~5%, lily 5%~7%,
Peach kernel 11%~13%, the root of kudzu vine 5%~7%, Semen sesami nigrum 5%~7%, spina date seed 5%~7%, mulberry fruit 5%~7%, dried orange peel
3%~5%, arillus longan 5%~7%, Poria cocos 5%~7%, sea-buckthorn 5%~7%, Radix Angelicae Sinensis 11%~13%, rhizoma imperatae 5%~
7%th, radix glycyrrhizae 3%~5%, the mass percent summation of above each component is 100%;
Step 2,
16 taste raw materials in step 1 are added water to cook twice, the water of first time plus 10 times of amounts are decocted 2 hours, are added for the second time
The water of 6 times of amounts, is decocted 2 hours, merges decocting liquid twice, filtering, it is 1.20~1.40 (60 DEG C) that filtrate, which is concentrated into relative density,
Thick paste;
Step 3,
Separately maltodextrin and potassium sorbate are taken, and maltodextrin and potassium sorbate were crushed into 80 mesh, it is standby;
Step 4,
By mass percentage, thick paste 24%~26.97%, the and of maltodextrin 73%~75.97% that step 1 is obtained are weighed
Potassium sorbate 0.01%~0.03%, the mass percent summation of above each component is 100%;Thick paste and water are stirred
To whitewashing, the weight ratio of thick paste and water is 1:2;
Step 5,
In multifunctional fluidized bed, maltodextrin and potassium sorbate are subjected to material heating and premixed, mixed material is obtained, so
Pelletized afterwards toward whitewashing on mixed material, finally dry, cool, discharging, shutdown;
Step 6,
Last whole grain and filling, is produced.
In above-mentioned steps 5, by maltodextrin and potassium sorbate be placed in it is multifunctional fluidized bed in, air quantity is set to 15m3/ h~
25m3/ h, EAT is set to 80 DEG C~100 DEG C, heating premix is carried out to material 7~15 minutes, obtains mixed material;In advance
It is mixed finish after, by adjusting air quantity and EAT so that mixed material temperature reaches 35 DEG C~40 DEG C, then multi-functional fluidisation
Bed starts whitewashing, and spouting velocity is set to 15rpm~20rpm, and atomizing pressure is 1.50bar~2.0bar, due to thing after whitewashing
Material is aggravated, temperature reduction, and air quantity is adjusted at any time and keeps material fully to jump, and regulation EAT keeps temperature of charge at any time
At 35 DEG C~40 DEG C, whitewashing is closed after whitewashing 15min~30min, granulation is completed;Multifunctional fluidized bed EAT is set again
It is set to 100 DEG C material is dried, regulation air quantity keeps material fully to jump, when the moisture≤2.0% of material, by air intake
Temperature is down to 25 DEG C~45 DEG C, the temperature of material is reduced to 25 DEG C~45 DEG C, finally discharging shutdown.
In above-mentioned steps 6, the particle that the dry particl that step 5 is obtained is chosen on shaking screen between the mesh of 14 mesh~60 is completed
The dry particl of selection, is then fitted into bag and completes filling by whole grain.
The beneficial effects of the invention are as follows:Have promoting blood circulation and removing blood stasis, fat eliminating, the work(of promoting qi circulation and relieving pain, to reach the mesh for the treatment of coronary heart disease
's;Whole prescription scientific compatibility, the property of medicine is gentle, and human body is had no toxic side effect, can long-term taking.
Embodiment
The present invention provides a kind of Chinese medicine composition for being used to treat coronary heart disease, by mass percentage, raw materials used by following
Component is constituted:
Hawthorn 5%~7%, Longstamen Onion Bulb 3%~5%, cloves 3%~5%, lily 5%~7%, peach kernel 11%~13%, Pueraria lobota
Root 5%~7%, Semen sesami nigrum 5%~7%, spina date seed 5%~7%, mulberry fruit 5%~7%, dried orange peel 3%~5%, arillus longan 5%
~7%, Poria cocos 5%~7%, sea-buckthorn 5%~7%, Radix Angelicae Sinensis 11%~13%, rhizoma imperatae 5%~7%, radix glycyrrhizae 3%~5%, with
The mass percent summation of upper each component is 100%.
The pharmacological action of Chinese medicine of the present invention is as follows:
Hawthorn:The sweet tepor returns spleen stomach Liver Channel food digesting stomach fortifying of acid, scattered stasis changes turbid lipid-loweringing;For meat stagnation, gastral cavilty is swollen
It is full, diarrhea dysentery abdominal pain, extravasated blood Amenorrhea, postpartum stasis, confidant sting, chest impediment and cardialgia, hernia pain, hyperlipidemia.
Longstamen Onion Bulb:Activate yang and remove abstruction, promoting the circulation of qi causes, for chest impediment and cardialgia, epigastric abdominal fullness distending pain, weight after rush down dysentery.
Cloves:It is pungent, temperature;Returns spleen stomach lung kidney channel middle benefit gas drop is inverse, tonifies the kidney and support yang;For deficiency-cold in spleen and stomach hiccup vomiting, deficiency of food is stopped
Rush down, trusted subordinate's crymodynia, impotence due to deficiency of the kidney.
Lily:It is sweet, tremble with fear, thoughts of returning home lung channel Yin nourishing and lung moistening, clearing away the heart fire and tranquillizing, for deficiency of Yin cough caused by dryness, consumptive disease is coughed hemoptysis, dysphoria palpitates with fear,
Insomnia and dreamful sleep, it is absent-minded.
Peach kernel:Promoting blood circulation, relaxes bowel, relieving cough and asthma, for amenorrhoea dysmenorrhoea, lung carbuncle acute appendicitis, injury from falling down, and intestinal dryness is just
It is secret, cough and asthma.
The root of kudzu vine:Expelling pathogenic factors from muscles and skin is brought down a fever, and is promoted the production of body fluid to quench thirst, promoting eruption, and Shengyang Zhixie is clearing and activating the channels and collaterals, relieving alcoholism, for fever caused by exogenous pathogens head
Bitterly, stiff nape and back, it is thirsty, quench one's thirst, measles without adequate eruption, hot dysentery, diarrhea, dizziness and headache, hemiplegia, chest impediment and cardialgia, during wine poison is hindered.
Semen sesami nigrum:Filling liver kidney, benefiting essence-blood, ease constipation is dry, for blood and essence asthenia, dizzy, Hiccough and deaf, poliosis,
Post disease alopecia, dry constipation of intestines.
Spina date seed:It is sweet, temperature, thoughts of returning home the spleen channel tonifying heart and spleen, nourishing blood and tranquilization;For insufficiency of vital energy and blood, palpitaition is seized with terror secondary, forgetful to lose
Sleep, blood deficiency chlorosis.
Mulberry fruit:Nourishing yin and supplementing blood, fluid dryness, for the deficiency of liver-yin and kidney-yin, dizziness and tinnitus, palpitation and insomnia, poliosis, Tianjin wound
Yearningly, Heat Diabetes, dry constipation of intestines.
Dried orange peel:Regulating qi-flowing for strengthening spleen is eliminating dampness and eliminating phlegm;For abdominal fullness and distention, deficiency of food is vomited and diarrhoea, coughing with a lot of sputum.
Arillus longan:It is sweet, temperature, thoughts of returning home the spleen channel tonifying heart and spleen, nourishing blood and tranquilization;For insufficiency of vital energy and blood, palpitaition is seized with terror secondary, forgetful to lose
Sleep, blood deficiency chlorosis.
Poria cocos:Clearing damp and promoting diuresis, invigorating the spleen, calming heart, for oedema oliguria, phlegm retention anti-dazzle nervous, spleen eating less, loose stool diarrhea, the mind
Uneasiness, insomnia of palpitating with fear.
Sea-buckthorn:It is sour and astringent, temperature, returns spleen stomach lung the heart channel of Hang-Shaoyin reinforcing spleen to promote digestion is relieving cough and reducing sputum, promoting blood circulation and removing blood stasis, for spleen eating less, dyspepsia
Stomachache, coughing with a lot of sputum, chest impediment and cardialgia, extravasated blood Amenorrhea, fall flutter the stasis of blood swell.
Radix Angelicae Sinensis:Replenishing and activating blood, menstruction regulating and pain relieving, moistening dryness for relaxing bowels, for blood deficiency chlorosis, dizziness palpitaition, irregular menstruation, dysmenorrhoea is closed
Through asthenia cold abdominalgia, arthralgia pain due to rheumatism, injury from falling down, ulcer sore wound, dry constipation of intestines.
Rhizoma imperatae:Cooling blood and hemostasis, reducing fever and causing diuresis is spitted blood for blood-head, hematuria, pyreticosis polydipsia, jaundice with damp-heat pathogen, oedema urine
It is few, puckery pain of heat gonorrhea.
Radix glycyrrhizae:It is sweet, put down;Thoughts of returning home lung taste are clearing heat and detoxicating through invigorating the spleen and benefiting qi, and remove phlegm and relieving cough, relieving spasm to stop pain, coordinating the drug actions of a prescription;
For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, four limbs contraction, carbuncle sore tumefacting virus alleviate medicine poison
Property is strong.
Coronary disease and angina pectoris is blood-stasis internal-depression chest, caused by depression and stagnation of QI, controls suitable promoting blood circulation and removing blood stasis, fat eliminating, promoting qi circulation and relieving pain.Root
According to《Chinese Pharmacopoeia》, peach kernel blood-breaking row is stagnant and moisturize in side;Sea-buckthorn promoting blood circulation is to relieve pain;Peach kernel and sea-buckthorn are monarch drug in a prescription altogether.Mountain
Short, bristly hair or beard, Longstamen Onion Bulb promoting blood circulation fat eliminating;Cloves pungent-warm dissipates row, Poria cocos promoting diuresis with drugs of tasteless flavour, principal drug assistance promoting blood circulation;Hawthorn, Longstamen Onion Bulb, cloves and
Poria cocos is ministerial drug altogether.Arillus longan, lily, Semen sesami nigrum, spina date seed, mulberry fruit, rhizoma imperatae, Radix Angelicae Sinensis, blood-nourishing benefit are cloudy, heat clearing and blood circulation promoting;It is old
The wide chest promoting the circulation of qi of skin;The root of kudzu vine is risen up to clear sun;Arillus longan, lily, Semen sesami nigrum, spina date seed, mulberry fruit, rhizoma imperatae, Radix Angelicae Sinensis, dried orange peel, the root of kudzu vine
For assistant.Radix glycyrrhizae coordinating the drug actions of a prescription, to make.All medicines share, plays promoting blood circulation and removing blood stasis, fat eliminating, the work(of promoting qi circulation and relieving pain, to reach conditioning heart altogether
Purpose.
Chinese medicine composition of the present invention is by the way of oral, oral 10 grams every time, 2 times a day, is within one month a course for the treatment of.
With reference to specific embodiment, the present invention is described in detail.
Embodiment 1
Preparation method for treating coronary heart disease Chinese medicine composition, including following operating procedure:
Step 1,
Hawthorn 5kg, Longstamen Onion Bulb 4kg, cloves 4kg, lily 7kg, peach kernel 12kg, root of kudzu vine 6kg, Semen sesami nigrum 7kg, spina date seed 6kg,
Mulberry fruit 5kg, dried orange peel 3kg, arillus longan 7kg, Poria cocos 7kg, sea-buckthorn 5kg, Radix Angelicae Sinensis 11kg, rhizoma imperatae 6kg, radix glycyrrhizae 5kg;
Step 2,
16 taste raw materials in step 1 are added water to cook twice, the water of first time plus 10 times of amounts are decocted 2 hours, are added for the second time
The water of 6 times of amounts, is decocted 2 hours, merges decocting liquid twice, filtering, and filtrate is concentrated into the thick paste that relative density is 1.35 (60 DEG C);
Step 3,
Separately maltodextrin and potassium sorbate are taken, and maltodextrin and potassium sorbate were crushed into 80 mesh, it is standby;
Step 4,
Weigh thick paste 20.5kg, maltodextrin 61.5kg and potassium sorbate 20g;Thick paste and water are uniformly mixing to obtain spray
The weight ratio of slurry, thick paste and water is 1:2;
Step 5,
By maltodextrin and potassium sorbate be placed in it is multifunctional fluidized bed in, air quantity is set to 20m3/ h, EAT is set
For 90 DEG C, heating premix is carried out to material 10 minutes, obtain mixed material;After premix is finished, by adjusting air quantity and entering wind-warm syndrome
Degree so that mixed material temperature reaches 36 DEG C, then multifunctional fluidized bed to start whitewashing, spouting velocity is set to 17rpm, is atomized
Pressure is 1.70bar, because material is aggravated after whitewashing, temperature reduction, and air quantity is adjusted at any time and keeps material fully to jump, and at any time
Regulation EAT makes temperature of charge close whitewashing after being maintained at 36 DEG C, whitewashing 20min, completes granulation;Again by multi-functional fluidisation
The EAT of bed is set to 100 DEG C material is dried, and regulation air quantity keeps material fully to jump, when material moisture≤
When 2.0%, EAT is down to 25 DEG C, the temperature of material is reduced to 25 DEG C, finally discharging shutdown;
Step 6,
The particle that the dry particl that step 5 is obtained is chosen on shaking screen between the mesh of 14 mesh~60 completes whole grain, then will
The dry particl of selection, which is fitted into bag, completes filling.
Embodiment 2
Preparation method for treating coronary heart disease Chinese medicine composition, including following operating procedure:
Step 1,
Hawthorn 6kg, Longstamen Onion Bulb 4kg, cloves 3kg, lily 6kg, peach kernel 11kg, root of kudzu vine 6kg, Semen sesami nigrum 5kg, spina date seed 7kg,
Mulberry fruit 6kg, dried orange peel 4kg, arillus longan 7kg, Poria cocos 6kg, sea-buckthorn 7kg, Radix Angelicae Sinensis 13kg, rhizoma imperatae 6kg, radix glycyrrhizae 3kg;
Step 2,
16 taste raw materials in step 1 are added water to cook twice, the water of first time plus 10 times of amounts are decocted 2 hours, are added for the second time
The water of 6 times of amounts, is decocted 2 hours, merges decocting liquid twice, filtering, and filtrate is concentrated into the thick paste that relative density is 1.20 (60 DEG C);
Step 3,
Separately maltodextrin and potassium sorbate are taken, and maltodextrin and potassium sorbate were crushed into 80 mesh, it is standby;
Step 4,
Weigh thick paste 24kg, maltodextrin 75.97kg and potassium sorbate 30g;Thick paste and water are uniformly mixing to obtain whitewashing,
The weight ratio of thick paste and water is 1:2;
Step 5,
By maltodextrin and potassium sorbate be placed in it is multifunctional fluidized bed in, air quantity is set to 25m3/ h, EAT is set
For 80 DEG C, heating premix is carried out to material 7 minutes, obtain mixed material;After premix is finished, by adjusting air quantity and entering wind-warm syndrome
Degree so that mixed material temperature reaches 40 DEG C, then multifunctional fluidized bed to start whitewashing, spouting velocity is set to 15rpm, is atomized
Pressure is 1.50bar, because material is aggravated after whitewashing, temperature reduction, and air quantity is adjusted at any time and keeps material fully to jump, and at any time
Regulation EAT makes temperature of charge close whitewashing after being maintained at 40 DEG C, whitewashing 15min, completes granulation;Again by multi-functional fluidisation
The EAT of bed is set to 100 DEG C material is dried, and regulation air quantity keeps material fully to jump, when material moisture≤
When 2.0%, EAT is down to 35 DEG C, the temperature of material is reduced to 35 DEG C, finally discharging shutdown;
Step 6,
The particle that the dry particl that step 5 is obtained is chosen on shaking screen between the mesh of 14 mesh~60 completes whole grain, then will
The dry particl of selection, which is fitted into bag, completes filling.
Embodiment 3
Preparation method for treating coronary heart disease Chinese medicine composition, including following operating procedure:
Step 1,
Hawthorn 7kg, Longstamen Onion Bulb 5kg, cloves 4kg, lily 5kg, peach kernel 12kg, root of kudzu vine 5kg, Semen sesami nigrum 6kg, spina date seed 7kg,
Mulberry fruit 6kg, dried orange peel 4kg, arillus longan 6kg, Poria cocos 5kg, sea-buckthorn 6kg, Radix Angelicae Sinensis 13kg, rhizoma imperatae 5kg, radix glycyrrhizae 4kg;
Step 2,
16 taste raw materials in step 1 are added water to cook twice, the water of first time plus 10 times of amounts are decocted 2 hours, are added for the second time
The water of 6 times of amounts, is decocted 2 hours, merges decocting liquid twice, filtering, and filtrate is concentrated into the thick paste that relative density is 1.30 (60 DEG C);
Step 3,
Separately maltodextrin and potassium sorbate are taken, and maltodextrin and potassium sorbate were crushed into 80 mesh, it is standby;
Step 4,
Weigh thick paste 26.97kg, maltodextrin 73kg and potassium sorbate 30g;Thick paste and water are uniformly mixing to obtain whitewashing,
The weight ratio of thick paste and water is 1:2;
Step 5,
By maltodextrin and potassium sorbate be placed in it is multifunctional fluidized bed in, air quantity is set to 15m3/ h, EAT is set
For 100 DEG C, heating premix is carried out to material 12 minutes, obtain mixed material;After premix is finished, by adjusting air quantity and entering wind-warm syndrome
Degree so that when mixed material temperature reaches 38 DEG C, then multifunctional fluidized bed to start whitewashing, spouting velocity is set to 18rpm, mist
Change pressure is 2.0bar, because material is aggravated after whitewashing, temperature reduction, and air quantity is adjusted at any time and keeps material fully to jump, and with
When regulation EAT temperature of charge is maintained at 38 DEG C, close whitewashing after whitewashing 30min, complete granulation;Again by multi-functional stream
The EAT of change bed is set to 100 DEG C and material is dried, and regulation air quantity keeps material fully to jump, when the moisture of material
When≤2.0%, EAT is down to 30 DEG C, the temperature of material is reduced to 30 DEG C, finally discharging shutdown;
Step 6,
The particle that the dry particl that step 5 is obtained is chosen on shaking screen between the mesh of 14 mesh~60 completes whole grain, then will
The dry particl of selection, which is fitted into bag, completes filling.
Embodiment 4
Preparation method for treating coronary heart disease Chinese medicine composition, including following operating procedure:
Step 1,
Hawthorn 5kg, Longstamen Onion Bulb 3kg, cloves 5kg, lily 5kg, peach kernel 13kg, root of kudzu vine 7kg, Semen sesami nigrum 5kg, spina date seed 5kg,
Mulberry fruit 7kg, dried orange peel 5kg, arillus longan 5kg, Poria cocos 6kg, sea-buckthorn 5kg, Radix Angelicae Sinensis 12kg, rhizoma imperatae 7kg, radix glycyrrhizae 5kg;
Step 2,
16 taste raw materials in step 1 are added water to cook twice, the water of first time plus 10 times of amounts are decocted 2 hours, are added for the second time
The water of 6 times of amounts, is decocted 2 hours, merges decocting liquid twice, filtering, and filtrate is concentrated into the thick paste that relative density is 1.40 (60 DEG C);
Step 3,
Separately maltodextrin and potassium sorbate are taken, and maltodextrin and potassium sorbate were crushed into 80 mesh, it is standby;
Step 4,
Weigh thick paste 24.02kg, maltodextrin 75.97kg and potassium sorbate 10g;Thick paste and water are uniformly mixing to obtain spray
The weight ratio of slurry, thick paste and water is 1:2;
Step 5,
By maltodextrin and potassium sorbate be placed in it is multifunctional fluidized bed in, air quantity is set to 20m3/ h, EAT is set
For 95 DEG C, heating premix is carried out to material 15 minutes, obtain mixed material;After premix is finished, by adjusting air quantity and entering wind-warm syndrome
Degree so that mixed material temperature reaches 35 DEG C, then multifunctional fluidized bed to start whitewashing, spouting velocity is set to 20rpm, is atomized
Pressure is 1.70bar, because material is aggravated after whitewashing, temperature reduction, and air quantity is adjusted at any time and keeps material fully to jump, and at any time
Regulation EAT makes temperature of charge close whitewashing after being maintained at 35 DEG C, whitewashing 25min, completes granulation;Again by multi-functional fluidisation
The EAT of bed is set to 100 DEG C material is dried, and regulation air quantity keeps material fully to jump, when material moisture≤
When 2.0%, EAT is down to 45 DEG C, the temperature of material is reduced to 45 DEG C, finally discharging shutdown;
Step 6,
The particle that the dry particl that step 5 is obtained is chosen on shaking screen between the mesh of 14 mesh~60 completes whole grain, then will
The dry particl of selection, which is fitted into bag, completes filling.
Clinical data:
1st, case selection:
In order to verify the effect of pharmaceutical composition of the present invention, in October, -2016 in January, 2015, the coronary heart disease made a definite diagnosis is selected
108 clinical observations of patient, patient is randomly divided into two groups;Treatment group 56, male 26, women 30, age 35-60 Sui,
Average age 47.8 years old, the course of disease 6 months~8 years, average course of disease is 3.62 years;Control group 52, male 28, women 24,
Age 36-58 Sui, average age 46.2 years old, the course of disease 6 months~8 years, average course of disease is 3.18 years.The course of disease of two groups of cases, disease
Shape light and heavy degree is basically identical, no significant difference, with comparativity.
Case inclusive criteria:The lighter's chest distress, unsmooth breath, severe one suffocating pain over the chest, or even chest pain radiating to the back, Shi Zuoshi
Only, break out weekly the Treating Patients of Angina Pectoris of more than 2 times;Palpitation and uneasiness, shortness of breath, burnout lazyness speech, lustreless complexion, dizzy mesh
It is dizzy, meet labor more very, purplish tongue, few tongue, thready and hesitant pulse;Electrocardioscopy has ischemic change.
Case exclusion standard:
(1) turn out to be on inspection miocardial infarction and other heart diseases, severe neurological functional disease, Climacteric,
Pectoralgia person caused by cervical spondylopathy;
(2) moderate above hypertension, severe cardiopulmonary insufficiency, severe arrhythmia cordis, liver, kidney, hemopoietic system etc. are merged
Severe primary disease, mental patient;
(3) severe patient with angina pectoris.
2nd, medicament selection:
Treatment group patient takes medicine of the present invention, and 2 times a day, each 10g, warm water delivery service in half an hour after meal, 30 days
For a course for the treatment of, 2 to 5 courses for the treatment of are continuously taken, serious patient increases the amount of discretion.
Control group patient takes Diaoxinxue Kang, and (Chengdu Di Ao pharmaceutical Co. Ltds produce, lot number:Chinese medicines quasi-word
20040102), by specification is taken, and 30 days are course for the treatment of, are continuously taken 2 to 5 months, and serious patient follows the doctor's advice increase at discretion use
Amount.
3rd, efficacy determination:
(1) cure:Symptom is wholly absent;Through Electrocardioscopy, reach normal.
(2) it is effective:Symptom disappears or basic disappearance;Through Electrocardioscopy, reach substantially normal.
(3) effectively:Panic attacks number of times, degree and duration have obvious mitigation;Through Electrocardioscopy, the drop of S-T segment
It is low, with more than rise 0.05mv after treatment, but not up to normal level, shoal in main lead negative T wave (up to 25% with
Upper person);Or T ripples are changed into upright from flat, chamber or intraventricular block improver;
(4) it is invalid:Clinical symptom and sign and Electrocardioscopy are unchanged.
4th, result:
In the treatment group for taking medicine of the present invention, 16 are cured, effective 23, effective 10, invalid 7, cure rate is
28.57%, total effective rate 87.5%.
10 are cured in control group, effective 18, effective 9, invalid 15, cure rate is 19.23%, total effective rate
71.15%.
Result above shows, the cure rate and total effective rate for the treatment of group are apparently higher than control group.
Case 1
Lee in Xianyang, Shanxi province city, man, 52 years old;Readme:Daily life is asymptomatic, occurs after motion or excessively work
Of short duration episode, each pain lasts are less than 5 minutes, and rest is lower or sublingual take pain after nitroglycerin and can disappear;Diagnosis
For:Slight labor angina;Take after Chinese medicine of the present invention, daily two doses (one 10g), 2 courses for the treatment of, symptom is clearly better,
Continue to take 2 courses for the treatment of, symptom disappears, through Electrocardioscopy, reach normal.
Case 2
50 years old, there is angina pectoris the year before in the Chen of Shaanxi Province Lantian County, female, feels acute for continuation at heart later
Strong constriction, pain, continue 5~10 minutes every time, and with symptoms such as low fever, dysphoria, dizziness, expiratory dyspnea;Through
Check:Electrocardiogram II, III, avF, V5, V6 ST-Segment move down 1.0~1.5mv;Chinese medicine of the present invention is taken, daily two doses (one
10g), after 3 courses for the treatment of, symptom is clearly better, only even to have slight pectoralgia;Continue to take 2 cycles, symptom disappears, through electrocardiogram
Check, reach normal.
Case 3
Shaanxi Province congratulates certain in Weinan City Fuping County, man, 60 years old, toward having history of coronary heart disease 3 years, often takes isosorbide dinitrate or nitric acid
Glycerine etc. is treated;There is hypertension history, the inspection ST-T that has an electro-cardiogram is inverted, left ventricular hypertrophy;Daily two doses are taken after this formula
After (one 10g), 3 courses for the treatment of, symptom is clearly better, and pectoralgia number of times is significantly reduced, and continues to take 2 courses for the treatment of, symptom disappears, warp
Electrocardioscopy, reaches normal.
Case 4
Shaanxi Province Hanzhong City Chenggu County Lee, man, 44 years old, readme:Had difficulty in breathing when doing physical labor within 2015, breath
It is very brief, have palpitation, shortness of breath, uncomfortable in chest, there being chest when serious violent burns sample pain;Examination in hospital is coronary heart disease, is controlled by medicine
Treat, though take a favorable turn, recurrent exerbation;Come here to go to a doctor, take after Chinese medicine of the present invention, daily two doses (one 10g), 3 courses for the treatment of,
Symptom substantially mitigates, and the number of times that symptom occurs is significantly reduced, and continues to take 2 courses for the treatment of, symptom disappears, through Electrocardioscopy, reached
To normal.
Claims (4)
1. the Chinese medicine composition for treating coronary heart disease, it is characterised in that by mass percentage, raw materials used by following components group
Into:
Hawthorn 5%~7%, Longstamen Onion Bulb 3%~5%, cloves 3%~5%, lily 5%~7%, peach kernel 11%~13%, the root of kudzu vine
5%~7%, Semen sesami nigrum 5%~7%, spina date seed 5%~7%, mulberry fruit 5%~7%, dried orange peel 3%~5%, arillus longan 5%~
7%th, Poria cocos 5%~7%, sea-buckthorn 5%~7%, Radix Angelicae Sinensis 11%~13%, rhizoma imperatae 5%~7%, radix glycyrrhizae 3%~5%, the above
The mass percent summation of each component is 100%.
2. it is used for the preparation method for treating coronary heart disease Chinese medicine composition described in a kind of claim 1, it is characterised in that including following
Operating procedure:
Step 1,
By mass percentage, hawthorn 5%~7%, Longstamen Onion Bulb 3%~5%, cloves 3%~5%, lily 5%~7%, peach kernel are weighed
11%~13%, the root of kudzu vine 5%~7%, Semen sesami nigrum 5%~7%, spina date seed 5%~7%, mulberry fruit 5%~7%, dried orange peel 3%~
5%th, arillus longan 5%~7%, Poria cocos 5%~7%, sea-buckthorn 5%~7%, Radix Angelicae Sinensis 11%~13%, rhizoma imperatae 5%~7%, sweet
Grass 3%~5%, the mass percent summation of above each component is 100%;
Step 2,
16 taste raw materials in step 1 are added water to cook twice, the water of 10 times of amounts are added for the first time, are decocted 2 hours, second plus 6 times
The water of amount, is decocted 2 hours, merges decocting liquid twice, filtering, it is the thick of 1.20~1.40 (60 DEG C) that filtrate, which is concentrated into relative density,
Cream;
Step 3,
Separately maltodextrin and potassium sorbate are taken, and maltodextrin and potassium sorbate were crushed into 80 mesh, it is standby;
Step 4,
By mass percentage, thick paste 24%~26.97%, maltodextrin 73%~75.97% and sorb that step 1 is obtained are weighed
Sour potassium 0.01%~0.03%, the mass percent summation of above each component is 100%;Thick paste and water are uniformly mixing to obtain spray
The weight ratio of slurry, thick paste and water is 1:2;
Step 5,
In multifunctional fluidized bed, maltodextrin and potassium sorbate are subjected to material heating and premixed, mixed material is obtained, it is then past
Whitewashing is pelletized on mixed material, is finally dried, cools, discharges, is shut down;
Step 6,
Last whole grain and filling, is produced.
3. it is used for the preparation method for treating coronary heart disease Chinese medicine composition according to claim 2, it is characterised in that:The step
In 5, by maltodextrin and potassium sorbate be placed in it is multifunctional fluidized bed in, air quantity is set to 15m3/ h~25m3/ h, EAT is set
80 DEG C~100 DEG C are set to, heating premix is carried out to material 7~15 minutes, mixed material is obtained;After premix is finished, pass through regulation
Air quantity and EAT so that mixed material temperature reaches 35 DEG C~40 DEG C, it is then multifunctional fluidized bed to start whitewashing, whitewashing speed
Degree is set to 15rpm~20rpm, and atomizing pressure is 1.50bar~2.0bar, because material is aggravated after whitewashing, temperature reduction, with
When regulation air quantity keep material fully to jump, and regulation EAT makes temperature of charge be maintained at 35 DEG C~40 DEG C at any time, whitewashing
Whitewashing is closed after 15min~30min, granulation is completed;Multifunctional fluidized bed EAT is set into 100 DEG C again to enter material
Row drying, regulation air quantity keeps material fully to jump, and when the moisture≤2.0% of material, EAT is down into 25 DEG C~45
DEG C, the temperature of material is reduced to 25 DEG C~45 DEG C, finally discharging shutdown.
4. it is used for the preparation method for treating coronary heart disease Chinese medicine composition according to claim 2, it is characterised in that:The step
In 6, the particle that the dry particl that step 5 is obtained is chosen on shaking screen between the mesh of 14 mesh~60 completes whole grain, then will choose
Dry particl be fitted into bag and complete filling.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710219548.9A CN107080805A (en) | 2017-04-06 | 2017-04-06 | Chinese medicine composition and preparation method for treating coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710219548.9A CN107080805A (en) | 2017-04-06 | 2017-04-06 | Chinese medicine composition and preparation method for treating coronary heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107080805A true CN107080805A (en) | 2017-08-22 |
Family
ID=59614309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710219548.9A Pending CN107080805A (en) | 2017-04-06 | 2017-04-06 | Chinese medicine composition and preparation method for treating coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107080805A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109589401A (en) * | 2019-01-29 | 2019-04-09 | 上海葆颐康医药科技有限公司 | A kind of tcm product and preparation method thereof for treating coronary heart disease |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102430085A (en) * | 2011-05-21 | 2012-05-02 | 苑芳胜 | Chinese medicine for treating coronary heart disease |
CN105796789A (en) * | 2014-12-14 | 2016-07-27 | 张雪松 | Traditional Chinese medicine preparation for treating coronary heart disease |
-
2017
- 2017-04-06 CN CN201710219548.9A patent/CN107080805A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102430085A (en) * | 2011-05-21 | 2012-05-02 | 苑芳胜 | Chinese medicine for treating coronary heart disease |
CN105796789A (en) * | 2014-12-14 | 2016-07-27 | 张雪松 | Traditional Chinese medicine preparation for treating coronary heart disease |
Non-Patent Citations (2)
Title |
---|
胡元会: "冠心病心绞痛中医诊疗方案(初稿)", 《中华中医药杂志》 * |
韦辉德等: "《全国名老中医验方选集》", 31 October 1989, 学术书刊出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109589401A (en) * | 2019-01-29 | 2019-04-09 | 上海葆颐康医药科技有限公司 | A kind of tcm product and preparation method thereof for treating coronary heart disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105031517A (en) | Dendrobium officinale healthcare tea capable of reducing blood fat, blood sugar, and blood pressure and preparation method thereof | |
CN107349360A (en) | For nursing one's health empty Chinese medicine composition of energy and blood of human body two and preparation method thereof | |
CN108144010A (en) | A kind of Chinese medicine composition and preparation method for treating cardiovascular and cerebrovascular disease | |
CN105687788A (en) | Pharmaceutical composition capable of softening blood vessels and application thereof | |
CN108295212A (en) | A kind of edible and medicinal alcohol and preparation method thereof | |
CN107080805A (en) | Chinese medicine composition and preparation method for treating coronary heart disease | |
CN107441401A (en) | Chinese medicine composition for three high drop and preparation method thereof | |
CN104017701B (en) | The logical health-care white spirit of a kind of the five internal organs weighing apparatus | |
CN103734609B (en) | Chinese medicinal noodles with effects in enhancing cardiac and cerebral blood supply, supplying oxygen, invigorating spleen, tonifying qi, nourishing blood and reinforcing kidney | |
CN103844164A (en) | Qi-tonifying and blood-nourishing porridge and preparation method thereof | |
CN106074765A (en) | A kind of Chinese medicine composition of sleep of calming the nerves, help | |
CN104799276B (en) | Panax notoginseng and gastrodia elata powder for promoting normal circulation of blood and thrombolysis, and preparation method thereof | |
CN103961578A (en) | Traditional Chinese medicine medicinal liquor for treating neurasthenia | |
CN105012732B (en) | Traditional Chinese medicine pill for treating sleep disorder syndrome and preparation method thereof | |
CN103845671B (en) | Warming YANG and invigorating QI in heart failure falls apart and preparation method | |
CN107854662A (en) | A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof | |
CN109464628A (en) | A kind of Chinese medicine composition for treating insomnia | |
CN107412679A (en) | Detoxifying health-care product and its preparation method and application | |
CN107617081A (en) | The Chinese medicine composition and its preparation and preparation method of a kind of hair growth | |
CN107375686A (en) | A kind of Chinese medicine composition and preparation method that can effectively treat vital myocarditis | |
CN106665776A (en) | Traditional Chinese medicine pastries for conditioning yin deficiency constitutions | |
CN105412643A (en) | Spray for treating pediatric water pathogen attacking heart type asthma and preparation method thereof | |
CN105267815A (en) | Spray for treating infant lung-kidney-deficiency type asthma and preparing method thereof | |
CN105214001B (en) | A kind of Chinese medicine composition for treating hypertensive patients coronary heart disease | |
CN106668494A (en) | Hui nationality traditional Chinese medicine astragalus membranaceus root stomach cancer-dispersing granules and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170822 |
|
RJ01 | Rejection of invention patent application after publication |